MedPath

Preimplantation genetic screening (PGS) in women of advanced maternal age

Completed
Conditions
Preimplantation genetic screening
Pregnancy and Childbirth
Registration Number
ISRCTN38014610
Lead Sponsor
Serono Nordic AB (Sweden)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
320
Inclusion Criteria

1. Couples with infertility of female or male origin
2. Intending to undergo IVF or intracytoplasmic sperm injection (ICSI)
3. Signed a written consent form
4. The age of the woman was over 38 years
5. The couple had to have at least three embryos of good morphological quality (GQE). After an amendment, owing to introduction of SET in Sweden in 2003, only two GQE were required.

Randomisation, using a data program, was performed on day three.

Exclusion Criteria

Previous enrolment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate, shown as foetal heart activity per randomised patient, measured six to seven weeks after the transfer of the embryo(s).
Secondary Outcome Measures
NameTimeMethod
1. Pregnancy rate per transfer, measured two weeks after the transfer of the embryo(s)<br>2. Rate of implantation, measured six to seven weeks after the transfer of the embryo(s) <br>3. Spontaneous abortion and delivery, measured by looking at hospital records throughout the nine months after the transfer of the embryo(s)
© Copyright 2025. All Rights Reserved by MedPath